Search concepts
|
Selected Filters
|
- 850 - 900 out of 1,291 results
Search results
-
Active
EP-CanGaroo Envelope During CIED Implant Registry Study Aziyo Biologics, Inc.
Dave, A., Mathuria, N., Schurmann, P. A. & Valderrábano, M.
10/11/21 → …
Project: Clinical Trial
-
A Randomized, Double-blind, Placebo-controlled, Phase 2b study to Evaluate Safety and Efficacy of DUR-928 in Subjects with Alcoholic Hepatitis
Victor, III, D. W., Kodali, S., Mobley, C. M. & Shetty, A.
10/5/21 → …
Project: Clinical Trial
-
Chemoprevention of Lung Cancer with Mitochondria-Targeted Honokiol
10/1/21 → 8/31/22
Project: Federal Funding Agencies
-
-
Texas Southern University Breast Cancer Prevention and Screening Center (TSU BCSPC)
10/1/21 → 8/31/22
Project: State
-
SH-ALIGN AR-HDE TAVR System for High Risk Sever AR JenaValve
Reardon, M. J., Faza, N., Goel, S., Kleiman, N. & Little, S. H.
9/29/21 → …
Project: Clinical Trial
-
Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy
Bernicker, E. H., Chan, E. Y., Heyne, K., Kim, M. P., Singh, M., Sultenfuss, M. A. & Zhang, J.
9/16/21 → …
Project: Clinical Trial
-
A Novel Multi-Antigen Vaccine (TNBCvax) to Prevent Triple Negative Breast Cancer
9/16/21 → 3/15/23
Project: Federal Funding Agencies
-
-
SH-TTVR Transfemoral System EFS for Tricuspid Regurgitation Medtronic
Goel, S., Faza, N., Guha, A., Kleiman, N., Little, S. H., Reardon, M. J., Valderrábano, M. & Yousefzai, R.
9/15/21 → …
Project: Clinical Trial
-
ROSE-LAWN Recovery and Outcome from StrokE-Longitudinal Assessment With Neuroimaging (ROSE-LAWN)
9/15/21 → …
Project: Clinical Trial
-
A Study to Test Safety and Efficacy of BI456906 in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3) Boehringer Ingelheim - BI 456906 NASH
Victor, III, D. W., Kodali, S. & Shetty, A.
9/15/21 → …
Project: Clinical Trial
-
AOCT - Phase3_MK4482-013_COVID-19
Moran, D., Gotur, D. B. & Zahiruddin, F.
9/15/21 → …
Project: Clinical Trial
-
Targeting Inflammation and Alloimmunity in Lung Transplant Recipients with Clazakizumab
9/14/21 → 6/30/22
Project: Federal Funding Agencies
-
ER stress response and chronic lymphocytic leukemia
Hu, A., Pingali, S. R. & Tang, C. A.
9/3/21 → …
Project: Clinical Trial
-
-
Safe Babies Evaluation Project: Mobile mental health support
9/1/21 → 8/31/22
Project: Federal Funding Agencies
-
SARS-CoV-2 and Precursors of Alzheimer Disease and Related Dementias: An Ultrahigh Field (7T) MRI Study in a Diverse Multinational Cohort
Roman, G. C., Vahidy, F. S. & Masdeu, J. C.
9/1/21 → 8/31/22
Project: Federal Funding Agencies
-
Chemoprevention of lung cancer by targeting lonidamine to mitochondria
You, M., Wang, Y., Xiong, D. & Zhang, Q.
9/1/21 → 8/31/24
Project: Federal Funding Agencies
-
-
-
-
-
Role of ATRA in Overcoming Myeloma Resistance to Proteasome Inhibitors
8/31/21 → 8/30/23
Project: State
-
Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma-CoImmune CMN-001-1
Satkunasivam, R., Singh, M. & Zhang, J.
8/26/21 → …
Project: Clinical Trial
-
Phase III_Parsaclisib and Ruxolitinib_Myelofibrosis_INCB 50465-313 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3K Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis
Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
8/23/21 → …
Project: Clinical Trial
-
Contemporary Classification of Myocardial Injury Events in MESA: Defining Distinct Risk Factor Associations with Myocardial Infarction Type 1-5 and Acute Non-Ischemic Myocardial Injury.
8/20/21 → 7/31/26
Project: Federal Funding Agencies
-
LIVERFASt Clinical performance evaluation of the LIVERFASt Tests to determine fibrosis staging, inflammatory activity and steatosis grading compared with Liver Biopsy in patients with metabolic factors and presumed Non-Alcoholic Fatty Liver Disease (NAFLD)
Kodali, S. & Victor, III, D. W.
8/18/21 → …
Project: Clinical Trial
-
-
A novel tool in high- dimensional single-cell space to predict neurotoxicity of CAR T cell therapies
8/1/21 → 7/31/26
Project: Federal Funding Agencies
-
Regulatory T cells as a novel therapeutic target in Alzheimer's Disease
Appel, S. H., Faridar, A. & Masdeu, J. C.
8/1/21 → 7/31/23
Project: Non Profit
-
Transfer Application - R01 CA223804 - Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer
8/1/21 → 7/31/22
Project: Federal Funding Agencies
-
Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer
8/1/21 → 7/31/22
Project: Federal Funding Agencies
-
Prevascularized encapsulation platform with local immunosuppression for Islet transplantation
8/1/21 → 7/31/23
Project: Non Profit
-
-
Non-invasive spinal neuromodulation and robotic exoskeleton to recover upper limb function after SCI
Sayenko, D., Horner, P. J. & Kaldis, T.
7/31/21 → 7/30/23
Project: Non Profit
-
VAS-WRAPSODY Endovascular Stent Graft for Hemodialysis Patients Merit Medical
Peden, E. K., Le, L., Rahimi, M. & Roy, T.
7/30/21 → …
Project: Clinical Trial
-
A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL, ACTIVE-CONTROLLED STUDY OF TRASTUZUMAB DERUXTECAN (T-DXd) VERSUS TRASTUZUMAB EMTANSINE (T-DM1) IN SUBJECTS WITH HIGH-RISK HER2 POSITIVE PRIMARY BREAST CANCER WHO HAVE RESIDUAL INVASIVE DISEASE IN BREAST OR AXILLARY LYMPH NODES FOLLOWING NEOADJUVANT THERAPY
Chang, J. C. & Niravath, P. A.
7/30/21 → …
Project: Clinical Trial